Product Information
DESLORATADINE 5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.2576 per EA under NDC 69452036320. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Feb 19, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Bionpharma Inc.NDC
69452036320
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESLORATADINEApproval Type
Generic (ANDA)
FDA Application
ANDA078357FDA Approved
2/19/2010
TE Code
AB
On Market Since
11/28/2023
Pharmacological Classes
Price Statistics
The NADAC for DESLORATADINE 5 MG TABLET has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2576 per EA |
|---|---|
| All-time high | $0.3435 (Apr 10, 2024) |
| All-time low | $0.2415 (Nov 20, 2024) |
| 52-week high | $0.3094 |
| 52-week low | $0.2553 |
| Median price | $0.2950 |
| Average price | $0.2885 |
| Largest weekly change | -24.4% (Nov 20, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desloratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESLORATADINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESLORATADINE 5 MG TABLET, manufactured by Bionpharma Inc., is $0.2576 per EA (NDC 69452036320), effective Sep 30, 2026.
How has the price of DESLORATADINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESLORATADINE 5 MG TABLET has declined 25.0%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for DESLORATADINE 5 MG TABLET?
Since Apr 10, 2024, the NADAC for DESLORATADINE 5 MG TABLET has ranged from a low of $0.2415 (Nov 20, 2024) to a high of $0.3435 (Apr 10, 2024), with a median of $0.2950 per EA.
Are there cheaper alternatives to DESLORATADINE 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DESLORATADINE 5 MG TABLET, is $0.2553 per EA — about 1% below DESLORATADINE 5 MG TABLET.
Who manufactures DESLORATADINE 5 MG TABLET?
DESLORATADINE 5 MG TABLET (NDC 69452036320) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.